I think every piece of the puzzle helps and perhaps the best...

I think every piece of the puzzle helps and perhaps the best strategic guidance the team provided was the R&D day that laid out all the studies. I think 008 in itself is not important so much as a an adjunct to 002 and the overall view of IPPS to treat OA. If the result is good it is one more piece of science that management can point to when applying for approval. I also think we underestimate the significance of the current fast track and the access we have to the FDA.

the capital raise like the last one is bullshit, too cheap and poor timing. If we were smarter we could have raised at a much better price with much less dilution. But it is what it is.I’m still hopeful Marco will continue with better communications..